Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013

(2017) Hyeyeun Lim et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

(2017) Nancy K Gillis et al.   LANCET ONCOLOGY

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

(2017) Koichi Takahashi et al.   LANCET ONCOLOGY

Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors

(2017) Theresa H. M. Keegan et al.   JAMA Oncology

Therapy-related myeloid neoplasms

(2016) Virginia M. Klimek et al.   CURRENT OPINION IN HEMATOLOGY

Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation

(2015) T Radivoyevitch et al.   LEUKEMIA

Thyroid cancer mortality and incidence: A global overview

(2014) Carlo La Vecchia et al.   INTERNATIONAL JOURNAL OF CANCER

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

(2014) Terrence N. Wong et al.   NATURE

Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care

(2013) J. S. de Moor et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001

(2013) Wan-Ling Hsu et al.   RADIATION RESEARCH

The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer, Based on Memorial Sloan-Kettering Cancer Center Risk Group Stratification

(2013) Iain J. Nixon et al.   THYROID

Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms

(2012) Valentina Nardi et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study

(2012) Mark S Pearce et al.   LANCET

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

(2012) Martin Schlumberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

(2012) Ujjal Mallick et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Pooled Analysis of Thyroid Cancer Incidence Following Radiotherapy for Childhood Cancer

(2012) Lene H. S. Veiga et al.   RADIATION RESEARCH

Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data

(2011) Reshma Jagsi et al.   CANCER

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy

(2011) N. Gopalakrishna Iyer et al.   CANCER

How to obtain the confidence interval from a P value

(2011) D. G. Altman et al.   BMJ-British Medical Journal

Dosimetry and thyroid cancer: the individual dosage of radioiodine

(2010) Michael Lassmann et al.   ENDOCRINE-RELATED CANCER

Risk of Myelodysplastic Syndromes in People Exposed to Ionizing Radiation: A Retrospective Cohort Study of Nagasaki Atomic Bomb Survivors

(2010) Masako Iwanaga et al.   JOURNAL OF CLINICAL ONCOLOGY

Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis

(2009) Anna M. Sawka et al.   THYROID

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

(2008) D. E. Rollison et al.   BLOOD